CM Management’s Cartesian Therapeutics RNAC Stock Holding History

CM Management’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,183	Closed	-$199K	–	69
2024 Q1	$199K	Sell	10,183 -13,150	-56%	-$279K	0.17%	68
2023 Q4	$483K	Hold	23,333	–	–	0.39%	57
2023 Q3	$742K	Hold	23,333	–	–	0.79%	42
2023 Q2	$784K	Buy	23,333 +3,333	+17%	+$119K	0.76%	41
2023 Q1	$834K	Hold	20,000	–	–	0.99%	39
2022 Q4	$678K	Hold	20,000	–	–	0.81%	42
2022 Q3	$984K	Hold	20,000	–	–	1.1%	33
2022 Q2	$786K	Buy	20,000 +3,333	+20%	+$98.8K	0.84%	40
2022 Q1	$615K	Buy	16,667 +3,334	+25%	+$209K	0.52%	57
2021 Q4	$1.3M	Hold	13,333	–	–	0.99%	32
2021 Q3	$1.66M	Hold	13,333	–	–	1.24%	28
2021 Q2	$1.67M	Hold	13,333	–	–	1.21%	29
2021 Q1	$1.81M	Buy	13,333 +2,500	+23%	+$310K	1.35%	20
2020 Q4	$985K	Buy	+10,833	New	+$939K	0.91%	37

Other funds holding RNAC

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return